PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $94,000 | +2.2% | 1,786 | -84.9% | 0.00% | -66.7% |
| Q1 2017 | $92,000 | -60.0% | 11,804 | +356.1% | 0.00% | -76.9% |
| Q1 2015 | $230,000 | +10.0% | 2,588 | +9.8% | 0.01% | 0.0% |
| Q4 2014 | $209,000 | -1.9% | 2,356 | +7.3% | 0.01% | -13.3% |
| Q3 2014 | $213,000 | -3.2% | 2,195 | -8.4% | 0.02% | -21.1% |
| Q2 2014 | $220,000 | – | 2,395 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |